Gene · 50848
Papers3,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Haematopoietic cell-derived exosomes in cancer development and therapeutics: From basic science to clinical practice. | Clin Transl Med | 2023 | 37830387 | PubTator, text mining | PubMed |
| Universal method for the isolation of microvessels from frozen brain tissue: A proof-of-concept multiomic investigation of the neurovasculature. | Brain Behav Immun Health | 2023 | 37822873 | PubTator, text mining | PubMed |
| Readability and reliability of online patient education materials about statins. | Am J Prev Cardiol | 2023 | 37822580 | PubTator, text mining | PubMed |
| Endothelial barrier dysfunction in systemic inflammation is mediated by soluble VE-cadherin interfering VE-PTP signaling. | iScience | 2023 | 37822505 | PubTator, text mining | PubMed |
| Early Progression of Abdominal Aortic Aneurysm is Decelerated by Improved Endothelial Barrier Function via ALDH2-LIN28B-ELK3 Signaling. | Adv Sci (Weinh) | 2023 | 37822152 | PubTator, text mining | PubMed |
| Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase Ib Trial. | Clin Cancer Res | 2023 | 37812476 | PubTator, text mining | PubMed |
| Vascular multiple sclerosis: addressing the pathogenesis, genetics, pro-angiogenic factors, and vascular abnormalities, along with the role of vascular intervention. | Ann Med Surg (Lond) | 2023 | 37811110 | PubTator, text mining | PubMed |
| Rapamycin Responds to Alzheimer's Disease: A Potential Translational Therapy. | Clin Interv Aging | 2023 | 37810956 | PubTator, text mining | PubMed |
| Human blood-labyrinth barrier model to study the effects of cytokines and inflammation. | Front Mol Neurosci | 2023 | 37808472 | PubTator, text mining | PubMed |
| Aflatoxin M1 decreases the expression of genes encoding tight junction proteins and influences the intestinal epithelial integrity. | Mycotoxin Res | 2023 | 37794205 | PubTator, text mining | PubMed |
| 25-hydroxycholesterol: an integrator of antiviral ability and signaling. | Front Immunol | 2023 | 37781400 | PubTator, text mining | PubMed |
| Single-cell analysis of bovine muscle-derived cell types for cultured meat production. | Front Nutr | 2023 | 37781115 | PubTator, text mining | PubMed |
| Case report: Novel insights into hemorrhagic destruction of the brain, subependymal calcification, and cataracts disease. | Front Pediatr | 2023 | 37780041 | PubTator, text mining | PubMed |
| Proportions and trends of critical care trials in leading general medical journals, 1970-2022. | Crit Care | 2023 | 37773187 | PubTator, text mining | PubMed |
| Centrosome amplification promotes cell invasion via cell-cell contact disruption and Rap-1 activation. | J Cell Sci | 2023 | 37772773 | PubTator, text mining | PubMed |
| The COVID-19 and chloroquine infodemic: Cross-sectional observational study of content analysis on YouTube. | PLoS One | 2023 | 37768899 | PubTator, text mining | PubMed |
| Insights Into Patients Questions Over Bunion Treatments: A Google Study. | Foot Ankle Orthop | 2023 | 37767008 | PubTator, text mining | PubMed |
| Significance of platelet adhesion-related genes in colon cancer based on non-negative matrix factorization-based clustering algorithm. | Digit Health | 2023 | 37766908 | PubTator, text mining | PubMed |
| Biomarkers and Functional Assays of Epithelial Barrier Disruption and Gastrointestinal Dysmotility in Critical Illness-A Narrative Review. | Nutrients | 2023 | 37764835 | PubTator, text mining | PubMed |
| Pathophysiology, Management, and Therapeutics in Subarachnoid Hemorrhage and Delayed Cerebral Ischemia: An Overview. | Pathophysiology | 2023 | 37755398 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/50848/papers?page=16